Publication | Closed Access

Oral delivery of taurocholic acid linked heparin–docetaxel conjugates for cancer therapy

Drug TargetingOncologyPolymer-drug ConjugateMedicineDrug Delivery SystemsOral DeliveryTumor TargetingTaurocholic AcidAnti-cancer AgentHeparin–docetaxel ConjugatesDrug Delivery SystemPharmacologyCancer Research